FDA 483 - 3DPX Medical - July 28, 2022

An FDA inspection of 3DFX Medical, a contract manufacturer in Chicago, IL, revealed significant quality system deficiencies. The firm failed to adequately document in-process inspections and tests, validate manufacturing processes and equipment, and maintain proper document control procedures. These issues indicate a lack of control over critical aspects of medical device manufacturing.